+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Multiplex Assay Market Size, Share & Trends Analysis Report by Product (Consumables, Software), by Application (R&D, Clinical Diagnostics), by Type, by Technology, by End-user, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • October 2022
  • Region: Global
  • Grand View Research
  • ID: 5681726
The global multiplex assay market size is expected to reach USD 3.87 billion by 2030, registering a CAGR of 8.27% from 2022 to 2030. The growing prevalence of infectious diseases is boosting the usage of multiplex assays in clinical trials. For instance, according to the American Cancer Society in 2021, 1.9 million cancer cases were reported along with 6,08,570 deaths in the United States. Multiplex assay aids in the diagnosis of cancer and reduces unnecessary invasive producers. Thus, growing chronic diseases can boost the necessity of these assays and is anticipated to fuel market growth. The increasing adoption of personalized medicine in recent years is another key factor driving the growth.

Personalized medicine is a precise medicine for an individual patient to attain improved treatment options based on the body type and disease risk. These assays ensure to be highly beneficial for the comprehensive diagnosis of personalized medicines. For instance, according to an article published in the MDPI journal in 2020, multiplex immunoassay provides a complete picture of the disease and pathways involved in Rheumatoid Arthritis (RA) and simultaneously analyzes multiple proteins that can yield biomarker signatures of RA subtypes to enable patients to benefit from personalized medicine. During the COVID-19 pandemic, multiplex testing continued to be an essential tool for healthcare professionals in effectively managing the spread of COVID-19. In addition, recently, several private companies have also developed novel versions of multiplex assays.

For instance, in Sept 2020, LabCorp launched an at-home collection version for diagnosis of influenza A/B, COVID-19, and respiratory syncytial virus single-panel tests. Furthermore, the advantages of multiplex assay over singleplex and traditional assay can boost the industry growth in coming years. Several benefits offered by these automated tests include microsampling capability, numerous arrays measured in a single trial, quicker results, high operational efficiency, easy operations, and reduced labor expenses. Thus, the industry has witnessed incremental growth in 2021 and is anticipated to have a similar trend during the forecast period. Moreover, increasing validation of the biomarkers in molecular & protein diagnostics and the rising need for high-throughput and automated systems are expected to create lucrative opportunities during the forecast period.

Multiple biomarker analysis has a wide range of applications in the area of infectious diseases, neurodegenerative diseases, autoimmune diseases, and cancer. Numerous biomarkers are being discovered, and there is a high possibility of the development of novel diagnostics. For instance, Cipla launched RT Direct multiplex PCR kit that delivers quicker results for COVID-19. Such developments can increase the market penetration of multiplex assay during the forecast period. The technological advancements and automation in the multiplex assay, improve the efficiency and speed of delivering accurate results. For instance, in July 2020, Luminex provided xMAP the INTELLIFLEX system to discover novel applications, including the exclusive ability to detect multiple antibodies in a single serology test.

In May 2022, Vela Diagnostics launched a highly automated multiplex PCR-based test for detecting antimicrobial resistance genes and UTI pathogens. Hence novel technological developments can fuel the industry growth in the near future. However, the high cost of equipment can restrict the usage of multiplex assays by researchers and manufacturers in mid and low-income countries. Also, the quality control standards and regulations are more stringent for multiplex assay compared to singlex assay, which can impede the industry growth during the forecast period.

Multiplex Assay Market Report Highlights

  • By product, the consumables segment held the dominant share in 2021. This is due to the recurring purchase of consumables along with the rise in the number of diagnostic tests
  • The protein multiplex assay type segment dominated the industry in 2021 due to the increasing focus on proteomics studies for biomarker research and clinical diagnostics
  • The flow cytometry technology segment held a larger share in 2021. Constant efforts by various companies to launch novel and technological advanced flow cytometer is the key factor driving the segment
  • The research & development application segment held the largest share in 2021due to the utilization of these assays in clinical & preclinical stages to evaluate toxicity, immunotherapy success, and drug response biomarkers
  • The pharmaceutical & biotechnology companies end-user segment led the industry in 2021due to a rise in pharma & biotech partnerships and collaborations to increase the multiplexing capabilities
  • North America dominated the global industry in 2021 due to the growing R&D activities as a result of the increasing prevalence of chronic diseases
  • Asia Pacific is estimated to register the fastest CAGRfrom 2022 to 2030 due to the rising number of hospitals in emerging countries, the developing R&D sector, and the high demand for healthcare infrastructure in the region


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Multiplex Assay Market

What is the estimated value of the Global Multiplex Assay Market?

The Global Multiplex Assay Market was estimated to be valued at $2.04 Billion in 2022.

What is the growth rate of the Global Multiplex Assay Market?

The growth rate of the Global Multiplex Assay Market is 8.2%, with an estimated value of $3.87 Billion by 2030.

What is the forecasted size of the Global Multiplex Assay Market?

The Global Multiplex Assay Market is estimated to be worth $3.87 Billion by 2030.

Who are the key companies in the Global Multiplex Assay Market?

Key companies in the Global Multiplex Assay Market include Bio, Rad Laboratories, Inc., Abcam plc., R&D Systems, Inc., Merck Kgaa, Assay Genie., Promega Connections, Qiagen N.V., Thermo Fisher Scientific and Luminex Corporation.

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global Multiplex Assay Market Variables, Trends, & Scope
4.1 Multiplex Assay Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Market Driver Analysis
4.3.1 Growing Prevalence Of Chronic And Infectious Diseases
4.3.2 Significant Advantages Of Multiplex Over Singleplex And Traditional Assays
4.3.3 Increasing Applications Of Multiplex Assays In Companion Diagnostics
4.3.4 Rising Awareness Of Early Diagnosis
4.4 Market Restraint Analysis
4.4.1 The High Investment Cost Of Multiplex Assays
4.4.2 Stringent Regulatory Constraints And Standards
4.5 Market Opportunity Analysis
4.5.1 Growing Need Of The High - Throughput And Automated Systems
4.5.2 Increasing Validation Of The Biomarkers In Protein And Molecular Diagnostics
4.6 COVID-19 Impact Analysis
4.7 Porter’s Five Forces Analysis
4.8 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Chapter 5 Multiplex Assay Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
5.1 Global Multiplex Assay Market: Product Movement Analysis
5.2 Consumables
5.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Instruments
5.3.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Software
5.4.1 Software market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Multiplex Assay Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
6.1 Global Multiplex Assay Market: Type Movement Analysis
6.2 Protein Multiplex Assays
6.2.1 Protein multiplex assays market estimates and forecast, 2018 - 2030 (USD Million)
6.2.1.1 Planar Protein Assays
6.2.1.1.1 Planar Protein Assays Market, 2018 - 2030 (USD Million)
6.2.1.Bead-Based Protein Assays
6.2.1.2.Bead-Based Protein Assays Market, 2018 - 2030 (USD Million)
6.3 Nucleic Acid Multiplex Assays
6.3.1 Nucleic Acid Multiplex Assays market estimates and forecast, 2018 - 2030 (USD Million)
6.3.1.1 Planar Protein Assays
6.3.1.1.1 Planar Protein Assays Market, 2018 - 2030 (USD Million)
6.3.1.Bead-Based Protein Assays
6.3.1.2.Bead-Based Protein Assays Market, 2018 - 2030 (USD Million)
6. Cell-based Multiplex Assays
6.4.1 Cell-Based Multiplex Assays market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Multiplex Assay Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)
7.1 Multiplex Assay Market: Technology Movement Analysis
7.2 Flow Cytometry
7.2.1 Flow Cytometry market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Fluorescence Detection
7.3.1 Fluorescence Detection market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Luminescence
7.4.1 Luminescence market estimates and forecast, 2018 - 2030, USD Million
7.5 MultipleReal-Time PCR
7.5.1 Multiplex Real-Time PCR market estimates and forecast, 2018 - 2030, USD Million
7.6 Other Technologies
7.5.1 Other Technologies market estimates and forecast, 2018 - 2030, USD Million
Chapter 8 Multiplex Assay Market: - Segment Analysis, by Application, 2018 - 2030 (USD Million)
8.1 Multiplex Assay Market: Application Movement Analysis
8.2 Research & Development
8.2.1 Research & Development market estimates and forecast, 2018 - 2030 (USD Million)
8.2.1.1 Drug Discovery & Development
8.2.1.1.1 Drug Discovery & Development Market, 2018 - 2030 (USD Million)
8.2.1.2 Biomarker Discovery & Validation
8.2.1.2.1 Biomarker Discovery & Validation Market, 2018 - 2030 (USD Million)
8.3 Clinical Diagnostics
8.3.1 Clinical Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
8.3.1.1 Infectious Diseases
8.3.1.1.1 Infectious Diseases Market, 2018 - 2030 (USD Million)
8.3.1.2 Cancer
8.3.1.2.1 Cancer Market, 2018 - 2030 (USD Million)
8.3.1.3 Cardiovascular Diseases
8.3.1.3.1 Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
8.3.1.4 Autoimmune Diseases
8.3.1.4.1 Autoimmune Diseases Market, 2018 - 2030 (USD Million)
8.3.1.5 Nervous System Disorders
8.3.1.5.1 Nervous System Disorders Market, 2018 - 2030 (USD Million)
8.3.1.6 Metabolism & Endocrinology Disorders
8.3.1.6.1 Metabolism & Endocrinology Disorders Market, 2018 - 2030 (USD Million)
8.3.1.7 Other Diseases
8.3.1.7.1 Other Diseases Market, 2018 - 2030 (USD Million)
Chapter 9 Multiplex Assay Market: - Segment Analysis, by End-user, 2018 - 2030 (USD Million)
9.1 Multiplex Assay Market: End-user Movement Analysis
9.2 Pharmaceutical & Biotechnology Companies
9.2.1 Pharmaceutical & Biotechnology Companies market estimates and forecast, 2018 - 2030 (USD Million)
9.3 Hospitals & Diagnostic laboratories
9.3.1 Hospitals & Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
9.4 Research & Academic Institutes
9.4.1 Research & Academic Institutes market estimates and forecast, 2018 - 2030 (USD Million)
9.5 Other End - users
9.5.1 Other End - users market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10 Multiplex Assay Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)
10.1 Multiplex Assay Market: Regional Movement Analysis
10.2 North America
10.2.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
10.2.2 U.S.
10.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.2.3 Canada
10.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3 Europe
10.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.2 U.K.
10.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.3. Germany
10.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.4 Spain
10.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.5 France
10.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.6 Italy
10.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.2 Japan
10.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.3 China
10.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.4 India
10.4.4.1 India Market Estimates And Forecast, 2018 - 2030
10.4.5 South Korea
10.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
10.4.6 Australia
10.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030
10.5 Latin America
10.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.2 Brazil
10.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.3 Mexico
10.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.4 Argentina
10.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
10.6 Middle East & Africa (MEA)
10.6.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
10.6.1 South Africa
10.6.1.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.2 Saudi Arabia
10.6.2.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
10.6.3 UAE
10.6.3.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 11 Competitive Landscape
11.1 Public Companies
11.1.1 Company market Position Analysis
11.1.2 Competitive Dashboard Analysis
11.1.3 Strategic Framework
11.2 Private Companies
11.2.1 List of Key Emerging Companies/Technology Disruptors/Innovators
11.2.2 Regional Network Map
11.4 Company Profiles
11.4.1 BIO - RAD LABORATORIES, INC.
11.4.1.1 Company Overview
11.4.1.2 Financial Performance
11.4.1.3 Product Benchmarking
11.4.1.4 Strategic Initiatives
11.4.2 ABCAM PLC.
11.4.2.1 Company Overview
11.4.2.2 Financial Performance
11.4.2.3 Product Benchmarking
11.4.2.4 Strategic Initiatives
11.4.3 R&D SYSTEMS, INC.
11.4.3.1 Company Overview
11.4.3.2 Financial Performance
11.4.3.3 Product Benchmarking
11.4.3.4 Strategic Initiatives
11.4.4 MERCK KGAA
11.4.4.1 Company Overview
11.4.4.2 Financial Performance
11.4.4.3 Product Benchmarking
11.4.4.4 Strategic Initiatives
11.4.5 ASSAY GENIE.
11.4.5.1 Company Overview
11.4.5.2 Financial Performance
11.4.5.3 Product Benchmarking
11.4.5.4 Strategic Initiatives
11.4.6 PROMEGA CONNECTIONS
11.4.6.1 Company Overview
11.4.6.2 Financial Performance
11.4.6.3 Product Benchmarking
11.4.6.4 Strategic Initiatives
11.4.7 QIAGEN N.V.
11.4.7.1 Company Overview
11.4.7.2 Financial Performance
11.4.7.3 Product Benchmarking
11.4.7.4 Strategic Initiatives
11.4.8 THERMO FISHER SCIENTIFIC
11.4.8.1 Company Overview
11.4.8.2 Financial Performance
11.4.8.3 Product Benchmarking
11.4.8.4 Strategic Initiatives
11.4.9 LUMINEX CORPORATION
11.4.9.1 Company Overview
11.4.9.2 Financial Performance
11.4.9.3 Product Benchmarking
11.4.9.4 Strategic Initiatives
11.4.10 PERKIN ELMER INC.
10.4.11.1 Company Overview
10.4.11.2 Financial Performance
10.4.11.3 Product Benchmarking
10.4.11.4 Strategic Initiatives
11.4.11 ADVANCED CELL DIAGNOSTICS, INC.
11.4.11.1 Company Overview
11.4.11.2 Financial Performance
11.4.11.3 Product Benchmarking
11.4.11.4 Strategic Initiatives
11.4.12 SEEGENE INC.
11.4.12.1 Company Overview
11.4.12.2 Financial Performance
11.4.12.3 Product Benchmarking
11.4.12.4 Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 4. Global Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 5. Global Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 6. Global Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 7. Global Multiplex Assay Market, by End-user, 2018-2030 (USD Million)
Table 8. Global Multiplex Assay Market, by Region, 2018-2030 (USD Million)
Table 9. North America Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 10. North America Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 11. North America Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 12. North America Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 13. North America Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 14. North America Multiplex Assay Market, by End-user, 2018-2030 (USD Million)
Table 15. U.S. Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 16. U.S. Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 17. U.S. Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 18. U.S. Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 19. U.S. Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 20. Canada Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 21. Canada Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 22. Canada Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 23. Canada Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 24. Canada Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 25. Europe Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 26. Europe Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 27. Europe Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 28. Europe Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 29. Europe Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 30. Europe Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 31. Germany Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 32. Germany Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 33. Germany Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 34. Germany Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 35. Germany Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 36. U.K. Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 37. U.K. Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 38. U.K. Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 39. U.K. Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 40. U.K. Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 41. France Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 42. France Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 43. France Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 44. France Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 45. France Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 46. Italy Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 47. Italy Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 48. Italy Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 49. Italy Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 50. Italy Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 51. Spain Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 52. Spain Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 53. Spain Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 54. Spain Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 55. Spain Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 56. Asia Pacific Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 57. Asia Pacific Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 58. Asia Pacific Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 59. Asia Pacific Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 60. Asia Pacific Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 61. Asia Pacific Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 62. China Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 63. China Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 64. China Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 65. China Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 66. China Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 67. Japan Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 68. Japan Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 69. Japan Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 70. Japan Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 71. Japan Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 72. India Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 73. India Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 74. India Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 75. India Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 76. India Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 77. South Korea Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 78. South Korea Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 79. South Korea Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 80. South Korea Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 81. South Korea Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 82. Australia Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 83. Australia Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 84. Australia Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 85. Australia Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 86. Australia Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 87. Latin America Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 88. Latin America Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 89. Latin America Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 90. Latin America Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 91. Latin America Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 92. Latin America Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 93. Brazil Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 94. Brazil Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 95. Brazil Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 96. Brazil Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 97. Brazil Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 98. Mexico Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 99. Mexico Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 100. Mexico Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 101. Mexico Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 102. Mexico Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 103. Argentina Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 104. Argentina Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 105. Argentina Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 106. Argentina Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 107. Argentina Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 108. Middle East & Africa Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 109. Middle East & Africa Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 110. Middle East & Africa Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 111. Middle East & Africa Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 112. Middle East & Africa Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 113. Middle East & Africa Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 114. South Africa Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 115. South Africa Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 116. South Africa Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 117. South Africa Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 118. South Africa Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 119. Saudi Arabia Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 120. Saudi Arabia Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 121. Saudi Arabia Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 122. Saudi Arabia Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 123. Saudi Arabia Multiplex Assay Market, End-user, 2018-2030 (USD Million)
Table 124. UAE Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 125. UAE Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 126. UAE Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 127. UAE Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 128. UAE Multiplex Assay Market, End-user, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Multiplex Assays Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 16 Global Multiplex Assay Market: Products Movement Analysis
Fig. 17 Global Multiplex Assay Market, for Consumables, 2018-2030 (USD Million)
Fig. 18 Global Multiplex Assay Market, for Instruments, 2018-2030 (USD Million)
Fig. 19 Global Multiplex Assay Market, for Software, 2018-2030 (USD Million)
Fig. 20 Global Multiplex Assay Market: Type Movement Analysis
Fig. 21 Global Multiplex Assay Market, for Protein Multiplex Assays, 2018-2030 (USD Million)
Fig. 22 Global Multiplex Assay Market, for Planar Protein Assays, 2018-2030 (USD Million)
Fig. 23 Global Multiplex Assay Market, for Bead-Based Protein Assays, 2018-2030 (USD Million)
Fig. 24 Global Multiplex Assay Market, for Nucleic Acid Multiplex Assays, 2018-2030 (USD Million)
Fig. 25 Global Multiplex Assay Market, for Planar Nucleic Acid Assays, 2018-2030 (USD Million)
Fig. 26 Global Multiplex Assay Market, for Bead-Based Nucleic Acid Assays, 2018-2030 (USD Million)
Fig. 27 Global Multiplex Assay Market, for Cell-Based Multiplex Assays, 2018-2030 (USD Million)
Fig. 28 Global Multiplex Assay Market: Technology Movement Analysis
Fig. 29 Global Multiplex Assay Market, for Flow Cytometry, 2018-2030 (USD Million)
Fig. 30 Global Multiplex Assay Market, for Fluorescence Detection, 2018-2030 (USD Million)
Fig. 31 Global Multiplex Assay Market, for Luminescence, 2018-2030 (USD Million)
Fig. 32 Global Multiplex Assay Market, for Multiplex Real-Time PCR, 2018-2030 (USD Million)
Fig. 33 Global Multiplex Assay Market, for Other Technologies, 2018-2030 (USD Million)
Fig. 34 Global Multiplex Assay Market: Application Movement Analysis
Fig. 35 Global Multiplex Assay Market, for Research & Development, 2018-2030 (USD Million)
Fig. 36 Global Multiplex Assay Market, for Drug Discovery & Development, 2018-2030 (USD Million)
Fig. 37 Global Multiplex Assay Market, for Biomarker Discovery & Validation, 2018-2030 (USD Million)
Fig. 38 Global Multiplex Assay Market, for Clinical Diagnostics, 2018-2030 (USD Million)
Fig. 39 Global Multiplex Assay Market, for Infectious Diseases, 2018-2030 (USD Million)
Fig. 40 Global Multiplex Assay Market, for Cancer, 2018-2030 (USD Million)
Fig. 41 Global Multiplex Assay Market, for Cardiovascular Diseases, 2018-2030 (USD Million)
Fig. 42 Global Multiplex Assay Market, for Autoimmune Diseases, 2018-2030 (USD Million)
Fig. 43 Global Multiplex Assay Market, for Nervous System Disorders, 2018-2030 (USD Million)
Fig. 44 Global Multiplex Assay Market, for Metabolism & Endocrinology Disorders, 2018-2030 (USD Million)
Fig. 45 Global Multiplex Assay Market, for Other Diseases, 2018-2030 (USD Million)
Fig. 46 Global Multiplex Assay Market: End-use Movement Analysis
Fig. 47 Global Multiplex Assay Market, for Pharmaceutical & Biotechnology Companies, 2018-2030 (USD Million)
Fig. 48 Global Multiplex Assay Market, for Hospitals & Diagnostic laboratories, 2018-2030 (USD Million)
Fig. 49 Global Multiplex Assay Market, for Research & Academic Institutes, 2018-2030 (USD Million)
Fig. 50 Global Multiplex Assay Market, for Other End-users, 2018-2030 (USD Million)
Fig. 51 Regional Marketplace: Key Takeaways
Fig. 52 Regional Outlook, 2021 & 2030
Fig. 53 Global Multiplex Assay Market: Region Movement Analysis
Fig. 54 North America Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 55 U.S. Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 56 Canada Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 57 Europe Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 58 Germany Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 59 U.K. Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 60 France Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 61 Italy Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 62 Spain Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 63 Asia Pacific Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 64 Japan Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 65 China Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 66 India Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 67 South Korea Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 68 Australia Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 69 Latin America Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 70 Brazil Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 71 Mexico Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 72 Argentina Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 73 Middle East and Africa Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 74 South Africa Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 75 Saudi Arabia Multiplex Assay Market, 2018-2030 (USD Million)
Fig. 76 UAE Multiplex Assay Market, 2018-2030 (USD Million)

Companies Mentioned

  • Bio - Rad Laboratories, Inc.
  • Abcam plc.
  • R&D Systems, Inc.
  • Merck Kgaa
  • Assay Genie.
  • Promega Connections
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Luminex Corporation
  • Perkin Elmer Inc.
  • Advanced Cell Diagnostics, Inc.
  • Seegene Inc.

Methodology

Loading
LOADING...